Real-time enrollment status for this refractory melanoma clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 7:17 PM UTC
| NCT Number | NCT07288112 |
| Recruiting Status | Recruiting |
| Condition | Refractory Melanoma |
| Phase | PHASE1 |
| Target Enrollment | 35 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Diakonos Oncology Corporation |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 30, 2026: Clinical trial NCT07288112 is currently recruiting participants. This phase1 study for refractory melanoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by Diakonos Oncology Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07288112 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07288112 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.